Epidemiology of Mixed Connective Tissue Disease, 1985-2014: A Population-Based Study
- PMID: 26946215
- PMCID: PMC5426802
- DOI: 10.1002/acr.22872
Epidemiology of Mixed Connective Tissue Disease, 1985-2014: A Population-Based Study
Abstract
Objective: To characterize the epidemiology of mixed connective tissue disease (MCTD) from 1983 to 2014.
Methods: An inception cohort of patients with incident MCTD in 1985-2014 in Olmsted County, Minnesota was identified based on comprehensive individual medical record review. Diagnosis of MCTD required fulfillment of at least 1 of the 4 widely accepted diagnostic criteria without fulfillment of classification criteria for other connective tissue diseases. Data were collected on demographic characteristics, clinical presentation, laboratory investigations, and mortality.
Results: A total of 50 incident cases of MCTD were identified (mean age 48.1 years and 84% were female). The annual incidence of MCTD was 1.9 per 100,000 population. Raynaud's phenomenon was the most common initial symptoms (50%), followed by arthralgia (30%) and swollen hands (16%). The diagnosis was frequently delayed with the median time from first symptom to fulfillment of criteria of 3.6 years. At fulfillment of criteria, arthralgia was the most prevalent manifestation (86%), followed by Raynaud's phenomenon (80%), swollen hands (64%), leukopenia/lymphopenia (44%), and heartburn (38%). Evolution to other connective tissue occurred infrequently with a 10-year rate of evolution of 8.5% and 6.3% for systemic lupus erythematosus and systemic sclerosis, respectively. The overall mortality was not different from the general population with a standardized mortality ratio of 1.1 (95% confidence interval 0.4-2.6).
Conclusion: This study was the first population-based study of MCTD to provide a complete picture of epidemiology and clinical characteristics of MCTD. MCTD occurred in about 2 persons per 100,000 per year. Evolution to other connective diseases occurred infrequently and the mortality was not affected.
© 2016, American College of Rheumatology.
Conflict of interest statement
Figures
Similar articles
-
Raynaud's phenomenon in mixed connective tissue disease.Rheum Dis Clin North Am. 2005 Aug;31(3):465-81, vi. doi: 10.1016/j.rdc.2005.04.006. Rheum Dis Clin North Am. 2005. PMID: 16084319 Review.
-
Mixed connective tissue disease associated with von Recklinghausen's neurofibromatosis.Intern Med. 2001 Apr;40(4):363-4. doi: 10.2169/internalmedicine.40.363. Intern Med. 2001. PMID: 11334401
-
Mixed connective tissue disease.Best Pract Res Clin Rheumatol. 2016 Feb;30(1):95-111. doi: 10.1016/j.berh.2016.03.002. Epub 2016 Apr 12. Best Pract Res Clin Rheumatol. 2016. PMID: 27421219 Review.
-
Diagnosis and risk stratification in patients with anti-RNP autoimmunity.Lupus. 2015 Sep;24(10):1057-66. doi: 10.1177/0961203315575586. Epub 2015 Mar 2. Lupus. 2015. PMID: 25736140 Free PMC article.
-
Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus.Dig Dis Sci. 1982 Jul;27(7):592-7. doi: 10.1007/BF01297214. Dig Dis Sci. 1982. PMID: 7083997
Cited by
-
Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives.Immunotargets Ther. 2023 Jul 26;12:79-89. doi: 10.2147/ITT.S390023. eCollection 2023. Immunotargets Ther. 2023. PMID: 37525698 Free PMC article. Review.
-
Incidence and Clinical Pattern of Mixed Connective Tissue Disease in Sudanese Patients at Omdurman Military Hospital: Hospital-Based Study.Open Access Rheumatol. 2021 Dec 9;13:333-341. doi: 10.2147/OARRR.S335206. eCollection 2021. Open Access Rheumatol. 2021. PMID: 34916856 Free PMC article.
-
Raynaud's phenomenon associated with psoriatic arthritis.BMJ Case Rep. 2024 Mar 5;17(3):e258215. doi: 10.1136/bcr-2023-258215. BMJ Case Rep. 2024. PMID: 38442964
-
Retinal Vasculitis and Choroidopathy in Pediatric-Onset Mixed Connective Tissue Disease.J Clin Rheumatol. 2017 Oct;23(7):400-401. doi: 10.1097/RHU.0000000000000591. J Clin Rheumatol. 2017. PMID: 28937479 Free PMC article. No abstract available.
-
Emergence of Smoldering ANCA-associated Glomerulonephritis during the Clinical Course of Mixed Connective Tissue Disease and Sjögren's Syndrome.Intern Med. 2018 Jun 15;57(12):1757-1762. doi: 10.2169/internalmedicine.9844-17. Epub 2017 Dec 21. Intern Med. 2018. PMID: 29269683 Free PMC article.
References
-
- Aringer M, Steiner G, Smolen JS. Does mixed connective tissue disease exist? Yes Rheum Dis Clin North Am. 2005;31:411–20. - PubMed
-
- Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease – an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA) Am J Med. 1972;52:148–59. - PubMed
-
- Kaipiainen-Seppanen O, Aho K. Incidence of rare systemic rheumatic and connective tissue diseases in Finland. J Intern Med. 1996;240:81–4. - PubMed
-
- Gunnarsson R, Molberg O, Gilboe IM, Gran JT. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011;70:1047–51. - PubMed
-
- Gendi NST, Welsh KI, van Venrooij WJ, Vancheeswaran R, Gilroy J, Black CK. HLA type as a predictor of mixed connective tissue disease differentiation: ten-year clinical and immunogenetic followup of 46 patients. Arthritis Rheum. 1995;38:259–66. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources